{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T08:50:02Z","timestamp":1794473402085,"version":"4.9.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T00:00:00Z","timestamp":1697068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T00:00:00Z","timestamp":1697068800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Egypt Heart J"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Stent thrombosis, a life-threatening complication of percutaneous coronary intervention (PCI) continues to occur despite effective antiplatelet regimens and improved stenting methods. Noncompliance with dual antiplatelet therapy is the most common etiology; however, in spite of timely and their optimum administration the rates of recurrent myocardial infarction (MI) and stent thrombosis remain high. Clopidogrel resistance is increasingly evoked with elevated risk of anterothrombotic events particularly in the setting of stent implantation. In this case report, we present a case of subacute stent thrombosis associated with clopidogrel resistance in a resource-constrained setting.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A 60\u00a0year old man with a long standing history of hypertension presented with a 6-month history of progressive shortness of breath. Initial electrocardiogram (ECG) revealed T-wave inversion on lateral leads and echocardiogram revealed akinetic basal lateral wall and hypokinetic mid lateral wall with reduced systolic functions. An elective coronary angiography (CAG) revealed a 90% stenosis of mid left anterior descending (LAD) artery and an 80% stenosis on the proximal left circumflex artery. He underwent a successful PCI with a drug-eluting stent implantation to mid LAD. He was discharged in a stable state 48\u00a0h post revascularization with dual antiplatelet (clopidogrel and acetylsalicylic acid). Seven days later, he presented with a crushing substernal chest pain. Cardiac enzymes were elevated and ECG revealed anterior ST-elevation MI. An emergency CAG revealed a high thrombus burden with 100% occlusion of mid LAD. Following unsuccessful ballooning, intravenous and intracoronary thrombolysis with tenecteplase was given. A TIMI II flow was achieved and the patient was sent to the coronary care unit. However, 14\u00a0h later there was yet a new onset of severe chest pain. A 12-lead ECG previewed anterior ST-elevation MI and the cardiac enzymes were high. Urgent CAG revealed in-stent thrombotic total occlusion of mid LAD. A stent in stent was then implanted and TIMI III flow was restored. Clopidogrel resistance was suspected and the patient was transitioned to ticagrelol. There were no further ischemic events during the remainder of hospitalization and the patient was discharged in a hemodynamically stable state three days later. During follow-up after one and three months, he was fairly stable without any further cardiac events.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Owing to clopidogrel resistance, stent thrombosis in the setting of dual antiplatelet therapy compliance may occur. While in a situation of clopidogrel resistance newer and more potent antiplatelet drugs should be used, their availability and cost remains a significant barrier particularly in the developing world. Nonetheless, a high index of suspicion and timely revascularization is fundamental to restore patency of the thrombosed vessel and confer better\u00a0risk-adjusted\u00a0survival\u00a0rates.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s43044-023-00408-8","type":"journal-article","created":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T13:02:14Z","timestamp":1697115734000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A nightmare of clopidogrel resistance in a resource-limited setting: case report of subacute stent thrombosis"],"prefix":"10.1186","volume":"75","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6720-5110","authenticated-orcid":false,"given":"Pedro","family":"Pallangyo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smita V.","family":"Bhalia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makrina","family":"Komba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zabella S.","family":"Mkojera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry A.","family":"Mayala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Engerasiya","family":"Kifai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter R.","family":"Kisenge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,12]]},"reference":[{"issue":"2","key":"408_CR1","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1161\/CIRCINTERVENTIONS.110.960872","volume":"4","author":"A Roguin","year":"2011","unstructured":"Roguin A (2011) Stent: the man and word behind the coronary metal prosthesis. Circ Cardiovasc Interv 4(2):206\u2013209","journal-title":"Circ Cardiovasc Interv"},{"issue":"11","key":"408_CR2","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1001\/jamacardio.2018.3551","volume":"3","author":"R Shah","year":"2018","unstructured":"Shah R, Rao SV, Latham SB, Kandzari DE (2018) Efficacy and safety of drug-eluting stents optimized for biocompatibility vs bare-metal stents with a single month of dual antiplatelet therapy: a meta-analysis. JAMA Cardiol 3(11):1050\u20131059","journal-title":"JAMA Cardiol"},{"key":"408_CR3","first-page":"cvac105","volume":"5","author":"J Nicolas","year":"2022","unstructured":"Nicolas J, Pivato CA, Chiarito M et al (2022) Evolution of drug-eluting coronary stents: a back-and-forth journey from the bench-to-bedside. Cardiovasc Res 5:cvac105","journal-title":"Cardiovasc Res"},{"issue":"6","key":"408_CR4","doi-asserted-by":"publisher","first-page":"706","DOI":"10.4244\/EIJ-D-17-00557","volume":"13","author":"GG Stefanini","year":"2017","unstructured":"Stefanini GG, Byrne RA, Windecker S, Kastrati A (2017) State of the art: coronary artery stents - past, present and future. EuroIntervention 13(6):706\u2013716","journal-title":"EuroIntervention"},{"issue":"1","key":"408_CR5","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13019-022-01812-y","volume":"17","author":"S Hassan","year":"2022","unstructured":"Hassan S, Ali MN, Ghafoor B (2022) Evolutionary perspective of drug eluting stents: from thick polymer to polymer free approach. J Cardiothorac Surg 17(1):65","journal-title":"J Cardiothorac Surg"},{"issue":"3","key":"408_CR6","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s40204-018-0097-y","volume":"7","author":"S Borhani","year":"2018","unstructured":"Borhani S, Hassanajili S, Ahmadi Tafti SH, Rabbani S (2018) Cardiovascular stents: overview, evolution, and next generation. Prog Biomater 7(3):175\u2013205","journal-title":"Prog Biomater"},{"issue":"10","key":"408_CR7","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1016\/j.hlc.2019.10.009","volume":"29","author":"R Batchelor","year":"2020","unstructured":"Batchelor R, Dinh D, Brennan A et al (2020) VCOR investigators. Incidence, predictors and clinical outcomes of stent thrombosis following percutaneous coronary intervention in contemporary practice. Heart Lung Circ 29(10):1433\u20131439","journal-title":"Heart Lung Circ"},{"key":"408_CR8","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.1016\/j.jacc.2011.08.007","volume":"58","author":"GN Levine","year":"2011","unstructured":"Levine GN, Bates ER, Blankenship JC et al (2011) 2011 ACCF\/AHA\/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol 58:e44\u2013e122","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"408_CR9","first-page":"e27240","volume":"14","author":"AA Khoso","year":"2022","unstructured":"Khoso AA, Soomro GH, Mal SB et al (2022) Frequency, risk factors, and outcome of definite stent thrombosis: a single-center experience. Cureus 14(7):e27240","journal-title":"Cureus"},{"issue":"1","key":"408_CR10","doi-asserted-by":"publisher","first-page":"62","DOI":"10.4244\/EIJV9I1A10","volume":"9","author":"J Iqbal","year":"2013","unstructured":"Iqbal J, Sumaya W, Tatman V et al (2013) Incidence and predictors of stent thrombosis: a single-centre study of 5,833 consecutive patients undergoing coronary artery stenting. EuroIntervention 9(1):62\u201369","journal-title":"EuroIntervention"},{"issue":"12","key":"408_CR11","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1016\/j.jcin.2015.05.026","volume":"8","author":"DJ Kereiakes","year":"2015","unstructured":"Kereiakes DJ, Yeh RW, Massaro JM et al (2015) DAPT study investigators. Stent thrombosis in drug-eluting or bare-metal stents in patients receiving dual antiplatelet therapy. JACC Cardiovasc Interv 8(12):1552\u20131562","journal-title":"JACC Cardiovasc Interv"},{"issue":"13","key":"408_CR12","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1056\/NEJMoa1607991","volume":"375","author":"KH B\u00f8naa","year":"2016","unstructured":"B\u00f8naa KH, Mannsverk J, Wiseth R et al (2016) NORSTENT investigators. Drug-eluting or bare-metal stents for coronary artery disease. N Engl J Med 375(13):1242\u20131252","journal-title":"N Engl J Med"},{"issue":"3","key":"408_CR13","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1007\/s11239-020-02184-7","volume":"51","author":"YX Yang","year":"2021","unstructured":"Yang YX, Liu Y, Li XW et al (2021) Clinical outcomes after percutaneous coronary intervention for early versus late and very late stent thrombosis: a systematic review and meta-analysis. J Thromb Thrombolysis 51(3):682\u2013692","journal-title":"J Thromb Thrombolysis"},{"key":"408_CR14","unstructured":"Raposeiras-Roub\u0131\u00b4n S, Emad Abu-Assi E, Fabrizio D\u2019Ascenzo F et al (2018) Annual incidence of confirmed stent thrombosis and clinical predictors in patients with ACS treated with ticagrelor or prasugrel. Rev Esp Cardiol 5"},{"key":"408_CR15","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/j.jcin.2014.05.017","volume":"7","author":"EJ Armstrong","year":"2014","unstructured":"Armstrong EJ, Sab S, Singh GD et al (2014) Predictors and outcomes of recurrent stent thrombosis: results from a multicenter registry. J Am Coll Cardiol Intv 7:1105\u20131113","journal-title":"J Am Coll Cardiol Intv"},{"key":"408_CR16","doi-asserted-by":"publisher","first-page":"748736","DOI":"10.1155\/2013\/748736","volume":"2013","author":"K Sudhir","year":"2013","unstructured":"Sudhir K, Hermiller JB, Ferguson JM, Simonton CA (2013) Risk factors for coronary drug-eluting stent thrombosis: influence of procedural, patient, lesion, and stent related factors and dual antiplatelet therapy. ISRN Cardiol 2013:748736","journal-title":"ISRN Cardiol"},{"issue":"7","key":"408_CR17","doi-asserted-by":"publisher","first-page":"e025341","DOI":"10.1161\/JAHA.122.025341","volume":"11","author":"GV Moukarbel","year":"2022","unstructured":"Moukarbel GV (2022) Coronary stent thrombosis and mortality: Does the relationship stand the test of time? J Am Heart Assoc 11(7):e025341","journal-title":"J Am Heart Assoc"},{"key":"408_CR18","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1016\/j.amjcard.2015.03.010","volume":"115","author":"EA Secemsky","year":"2015","unstructured":"Secemsky EA, Matteau A, Yeh RW et al (2015) PROTECT trial investigators. Comparison of short- and long-term cardiac mortality in early versus late stent thrombosis (from Pooled PROTECT Trials). Am J Cardiol 115:1678\u20131684","journal-title":"Am J Cardiol"},{"issue":"1","key":"408_CR19","doi-asserted-by":"publisher","first-page":"24","DOI":"10.5334\/gh.1112","volume":"17","author":"R Kumar","year":"2022","unstructured":"Kumar R, Ammar A, Saghir T et al (2022) Incidence, predictors, and outcomes of acute and subacute stent thrombosis after emergency percutaneous coronary revascularization with drug-eluting stents: a prospective observational study. Glob Heart 17(1):24","journal-title":"Glob Heart"},{"key":"408_CR20","first-page":"199","volume":"8","author":"A Gerhart","year":"2022","unstructured":"Gerhart A (2022) Outcomes and risk factors for stent thrombosis. J Thrombo Cir 8:199","journal-title":"J Thrombo Cir"},{"key":"408_CR21","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","volume":"348","author":"CAPRIE Steering Committee","year":"1996","unstructured":"CAPRIE Steering Committee (1996) A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 348:1329\u20131339","journal-title":"Lancet"},{"key":"408_CR22","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1001\/archinte.164.19.2106","volume":"164","author":"J Hirsch","year":"2004","unstructured":"Hirsch J, Bhatt DL (2004) Comparative benefits of clopidogrel and aspirin in high-risk patient populations. Arch Intern Med 164:2106\u20132110","journal-title":"Arch Intern Med"},{"key":"408_CR23","doi-asserted-by":"crossref","unstructured":"(2001) The clopidogrel in unstable angina to prevent recurrent events trial investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 345:494\u2013502","DOI":"10.1056\/NEJMoa010746"},{"key":"408_CR24","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/S0140-6736(01)05701-4","volume":"358","author":"SR Mehta","year":"2001","unstructured":"Mehta SR, Yusuf S, Peters RJG et al (2001) Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 358:527\u2013533","journal-title":"Lancet"},{"key":"408_CR25","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1001\/jama.288.19.2411","volume":"288","author":"SR Steinhubl","year":"2002","unstructured":"Steinhubl SR, Berger PB, Mann JT III et al (2002) For the CREDO Investigators. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA 288:2411\u20132420","journal-title":"JAMA"},{"key":"408_CR26","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1056\/NEJMoa050522","volume":"352","author":"MS Sabatine","year":"2005","unstructured":"Sabatine MS, Cannon CP, Gibson CM et al (2005) The CLARITY-TIMI 28 investigators. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with STsegment elevation. N Engl J Med 352:1179\u20131189","journal-title":"N Engl J Med"},{"key":"408_CR27","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1016\/S0140-6736(05)67660-X","volume":"366","author":"Z Chen","year":"2005","unstructured":"Chen Z, Jiang L, Chen Y et al (2005) Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet 366:1607\u20131621","journal-title":"Lancet"},{"issue":"4","key":"408_CR28","first-page":"e23973","volume":"14","author":"N Nso","year":"2022","unstructured":"Nso N, Nassar M, Zirkiyeva M et al (2022) Factors impacting stent thrombosis in patients with percutaneous coronary intervention and coronary stenting: a systematic review and meta-analysis. Cureus. 14(4):e23973","journal-title":"Cureus."},{"issue":"3","key":"408_CR29","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.3390\/jcm12031238","volume":"12","author":"F Condello","year":"2023","unstructured":"Condello F, Spaccarotella C, Sorrentino S et al (2023) Stent thrombosis and restenosis with contemporary drug-eluting stents: predictors and current evidence. J Clin Med 12(3):1238","journal-title":"J Clin Med"},{"key":"408_CR30","doi-asserted-by":"publisher","first-page":"62","DOI":"10.18773\/austprescr.2010.028","volume":"33","author":"AJ McLachlan","year":"2010","unstructured":"McLachlan AJ, Campbell TJ (2010) Variability in response to clopidogrel. Aust Prescr 33:62\u201363","journal-title":"Aust Prescr"},{"key":"408_CR31","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.thromres.2006.11.012","volume":"120","author":"P Harrison","year":"2007","unstructured":"Harrison P, Frelinger AL, Furman MI, Michelson AD (2007) Measuring antiplatelet drug effects in the laboratory. Thromb Res 120:323\u2013336","journal-title":"Thromb Res"},{"key":"408_CR32","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.thromres.2006.08.012","volume":"120","author":"A Gurbel Paul","year":"2007","unstructured":"Gurbel Paul A, Tantry US (2007) Clopidogrel resistance? Thromb Res 120:311\u2013321","journal-title":"Thromb Res"},{"key":"408_CR33","doi-asserted-by":"publisher","first-page":"194","DOI":"10.9734\/jpri\/2021\/v33i64A35319","volume":"33","author":"T Alrahbeni","year":"2021","unstructured":"Alrahbeni T (2021) New perspectives on clopidogrel resistance systematic review and meta-analysis. J Pharm Res Int 33:194\u2013202","journal-title":"J Pharm Res Int"},{"issue":"1","key":"408_CR34","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1177\/17085381211059394","volume":"31","author":"AM Berenson","year":"2023","unstructured":"Berenson AM, Hawken TN, Fort DG et al (2023) Clopidogrel resistance is common in patients undergoing vascular and coronary interventions. Vascular 31(1):58\u201363","journal-title":"Vascular"},{"issue":"8","key":"408_CR35","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1016\/j.jacc.2005.01.034","volume":"45","author":"TA Nguyen","year":"2005","unstructured":"Nguyen TA, Diodati JG, Pharand C (2005) Resistance to clopidogrel: a review of the evidence. J Am Coll Cardiol 45(8):1157\u20131164","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"408_CR36","first-page":"e4","volume":"145","author":"JS Lawton","year":"2022","unstructured":"Lawton JS, Tamis-Holland JE, Bangalore S et al (2022) 2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: executive summary: a report of the american college of cardiology\/American heart association joint committee on clinical practice guidelines. Circulation 145(3):e4\u2013e17","journal-title":"Circulation"},{"issue":"22","key":"408_CR37","first-page":"00202","volume":"S1550\u20138307","author":"B Liang","year":"2022","unstructured":"Liang B, Li R, Lu J, Tian XJ, Gu N (2022) Tongue diagnostic parameters-based diagnostic signature in coronary artery disease patients with clopidogrel resistance after percutaneous coronary intervention. Explore (NY) S1550\u20138307(22):00202\u201300206","journal-title":"Explore (NY)"},{"issue":"2","key":"408_CR38","doi-asserted-by":"publisher","first-page":"94","DOI":"10.32596\/ejcm.galenos.2021-02-012","volume":"9","author":"D Karabulut","year":"2021","unstructured":"Karabulut D, Kaya A, Abac\u0131 O et al (2021) The frequency of aspirin and clopidogrel resistance and related factors in patients undergoing elective percutaneous coronary intervention. EJCM 9(2):94\u2013104","journal-title":"EJCM"},{"issue":"1","key":"408_CR39","doi-asserted-by":"publisher","first-page":"194","DOI":"10.3390\/jcm9010194","volume":"9","author":"P Fontana","year":"2020","unstructured":"Fontana P, Roffi M, Reny JL (2020) Platelet function test use for patients with coronary artery disease in the early 2020s. J Clin Med 9(1):194","journal-title":"J Clin Med"},{"issue":"1","key":"408_CR40","doi-asserted-by":"publisher","first-page":"e021107","DOI":"10.1161\/JAHA.120.021107","volume":"11","author":"H Yao","year":"2022","unstructured":"Yao H, Ekou A, Niamkey T et al (2022) Acute coronary syndromes in sub-saharan africa: a 10-year systematic review. J Am Heart Assoc 11(1):e021107","journal-title":"J Am Heart Assoc"}],"container-title":["The Egyptian Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43044-023-00408-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43044-023-00408-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43044-023-00408-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T20:10:21Z","timestamp":1700338221000},"score":1,"resource":{"primary":{"URL":"https:\/\/tehj.springeropen.com\/articles\/10.1186\/s43044-023-00408-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,12]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["408"],"URL":"https:\/\/doi.org\/10.1186\/s43044-023-00408-8","relation":{},"ISSN":["2090-911X"],"issn-type":[{"value":"2090-911X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,12]]},"assertion":[{"value":"10 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in this study were per the ethical standards of the institutional review board of Jakaya Kikwete Cardiac Institute and with the 1964 Helsinki declaration and its later amendments.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent was obtained from the participant.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. The consent form is available upon request.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"85"}}